Program is based on a minimum of 25% of time allowed for questions and answers
| 7:30 – 8:00 am | Self-guided Orientation to Online Platform | |
| 8:00 – 8:15 am | WELCOME & INTRODUCTIONS | Chair: Dr. Andre Schuh |
| 8:15 – 8:45 am | MPN Update 2022 Includes 10 min Q & A |
Dr. Dawn Maze Princess Margaret Cancer Centre |
| 8:45 – 9:15 am | MDS Update 2022 Includes 15 min Q&A |
Dr. Rena Buckstein Sunnybrook Regional Cancer Centre |
| 9:15 – 10:15 am | Intensive vs. Non-Intensive Therapy of AML in the Elderly: How to Choose Includes 15 min Q&A |
Dr. Mohamed Sorror Fred Hutchinson Cancer Center Seattle, USA |
| 10:15– 10:30 am | BREAK | |
| 10:30 – 11:30 am | The 2022 ELN and WHO acute leukemia classification systems… How are treatment decisions affected? Includes 15 min Q & A |
Dr. Hartmut Döhner Universitätsklinikum Ulm Ulm, Germany |
| 11:30 – 12:45 pm | Lunch Breakout Topic: Optical Genome Mapping in Leukemia, 2022 Update | Dr. Adam Smith University Health Network/ Princess Margaret Cancer Centre |
| 11:30 – 12:45 pm | Nursing Lunch Symposia Topic: TBA | Cindy Murray NP Kirsten Lewis NP Shannon Nixon NP |
| 12:45 – 1:45 pm | Karen Meltzer Lecture: Ph+ve ALL in 2022 Includes 15 min Q & A |
Dr. Robin Foà Sapienza University of Rome Rome, Italy |
| 1:45– 2:15 pm | Controversy on the later line treatment option in CML Includes 10 min Q & A |
Dr. Dennis Kim Princess Margaret Cancer Centre |
| 2:15 – 2:45 pm | CLL Update 2022 Includes 10 min Q & A |
Dr. Versha Banerji Cancer Care Manitoba Winnipeg |
| 2:45 pm | Evaluation and Closing | Dr. Andre Schuh |